These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 188866
1. Collagenase and collagenase inhibitors in osteoarthritic and normal cartilage. Ehrlich MG, Mankin HJ, Jones H, Wright R, Crispen C, Vigliani G. J Clin Invest; 1977 Feb; 59(2):226-33. PubMed ID: 188866 [Abstract] [Full Text] [Related]
2. The role of proteases in the pathogenesis of osteoarthritis. Ehrlich MG, Armstrong AL, Treadwell BV, Mankin HJ. J Rheumatol; 1987 May; 14 Spec No():30-2. PubMed ID: 3040991 [Abstract] [Full Text] [Related]
4. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Dahlberg L, Billinghurst RC, Manner P, Nelson F, Webb G, Ionescu M, Reiner A, Tanzer M, Zukor D, Chen J, van Wart HE, Poole AR. Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762 [Abstract] [Full Text] [Related]
5. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway. Yasuda T, Poole AR. Arthritis Rheum; 2002 Jan; 46(1):138-48. PubMed ID: 11817586 [Abstract] [Full Text] [Related]
6. Hepatocyte growth factor induction of collagenase 3 production in human osteoarthritic cartilage: involvement of the stress-activated protein kinase/c-Jun N-terminal kinase pathway and a sensitive p38 mitogen-activated protein kinase inhibitor cascade. Reboul P, Pelletier JP, Tardif G, Benderdour M, Ranger P, Bottaro DP, Martel-Pelletier J. Arthritis Rheum; 2001 Jan; 44(1):73-84. PubMed ID: 11212179 [Abstract] [Full Text] [Related]
7. Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis. Sabatini M, Lesur C, Thomas M, Chomel A, Anract P, de Nanteuil G, Pastoureau P. Arthritis Rheum; 2005 Jan; 52(1):171-80. PubMed ID: 15641085 [Abstract] [Full Text] [Related]
8. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase. Billinghurst RC, Wu W, Ionescu M, Reiner A, Dahlberg L, Chen J, van Wart H, Poole AR. Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761 [Abstract] [Full Text] [Related]
9. Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1. Dodge GR, Poole AR. J Clin Invest; 1989 Feb; 83(2):647-61. PubMed ID: 2783591 [Abstract] [Full Text] [Related]
10. Potent collagenase inhibitors prevent interleukin-1-induced cartilage degradation in vitro. Nixon JS, Bottomley KM, Broadhurst MJ, Brown PA, Johnson WH, Lawton G, Marley J, Sedgwick AD, Wilkinson SE. Int J Tissue React; 1991 Feb; 13(5):237-41. PubMed ID: 1666894 [Abstract] [Full Text] [Related]
11. Efficacy and mechanism of action of KHBJ-9B, a new herbal medicine, and its major compound triterpenoids in human cartilage culture and in a rabbit model of collagenase-induced osteoarthritis. Huh JE, Baek YH, Ryu SR, Lee JD, Choi DY, Park DS. Int Immunopharmacol; 2009 Feb; 9(2):230-40. PubMed ID: 19100343 [Abstract] [Full Text] [Related]
12. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13. Wu W, Billinghurst RC, Pidoux I, Antoniou J, Zukor D, Tanzer M, Poole AR. Arthritis Rheum; 2002 Aug; 46(8):2087-94. PubMed ID: 12209513 [Abstract] [Full Text] [Related]
13. Influence of chloroquine and other substances on the collagenolytic activity in human osteoarthritic cartilage in vitro. Schug BS, Kalbhen DA. Arzneimittelforschung; 1995 Mar; 45(3):285-9. PubMed ID: 7741786 [Abstract] [Full Text] [Related]
14. Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways. Milner JM, Elliott SF, Cawston TE. Arthritis Rheum; 2001 Sep; 44(9):2084-96. PubMed ID: 11592371 [Abstract] [Full Text] [Related]
15. Increased degradation and altered tissue distribution of cartilage oligomeric matrix protein in human rheumatoid and osteoarthritic cartilage. Di Cesare PE, Carlson CS, Stolerman ES, Hauser N, Tulli H, Paulsson M. J Orthop Res; 1996 Nov; 14(6):946-55. PubMed ID: 8982138 [Abstract] [Full Text] [Related]
17. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, Mitchell P, Hambor J, Diekmann O, Tschesche H, Chen J, Van Wart H, Poole AR. J Clin Invest; 1997 Apr 01; 99(7):1534-45. PubMed ID: 9119997 [Abstract] [Full Text] [Related]
18. Direct extraction and assay of collagenase from human osteoarthritic articular cartilage. Blanckaert A, Mazières B, Eeckhout Y, Vaes G. Clin Chim Acta; 1989 Oct 31; 185(1):73-9. PubMed ID: 2559818 [Abstract] [Full Text] [Related]
19. Effects of interleukin-1 and anti-inflammatory drugs on the degradation of human articular cartilage. Shinmei M, Kikuchi T, Masuda K, Shimomura Y. Drugs; 1988 Oct 31; 35 Suppl 1():33-41. PubMed ID: 2834169 [Abstract] [Full Text] [Related]
20. Modulation of collagenase 3 in human osteoarthritic cartilage by activation of extracellular transforming growth factor beta: role of furin convertase. Moldovan F, Pelletier JP, Mineau F, Dupuis M, Cloutier JM, Martel-Pelletier J. Arthritis Rheum; 2000 Sep 31; 43(9):2100-9. PubMed ID: 11014362 [Abstract] [Full Text] [Related] Page: [Next] [New Search]